Samsara BioCapital, LLC - Q4 2023 holdings

 Value Shares↓ Weighting
ExitSURROZEN INC*w exp 08/01/203$0-99,999
-100.0%
-0.00%
NUVBWS ExitNUVATION BIO INC*w exp 07/07/202$0-133,333
-100.0%
-0.00%
KRON ExitKRONOS BIO INC$0-78,131
-100.0%
-0.03%
ALVR ExitALLOVIR INC$0-82,336
-100.0%
-0.05%
ExitSCIENCE 37 HOLDINGS INC$0-900,000
-100.0%
-0.11%
ALLK ExitALLAKOS INC$0-172,089
-100.0%
-0.12%
VIRX ExitVIRACTA THERAPEUTICS INC$0-689,709
-100.0%
-0.22%
VTVT ExitVTV THERAPEUTICS INCcl a$0-1,635,509
-100.0%
-0.24%
ExitLEAP THERAPEUTICS INC$0-602,203
-100.0%
-0.25%
TERN ExitTERNS PHARMACEUTICALS INC$0-202,348
-100.0%
-0.31%
BOLT ExitBOLT BIOTHERAPEUTICS INC$0-1,049,153
-100.0%
-0.33%
IGMS ExitIGM BIOSCIENCES INC$0-154,664
-100.0%
-0.40%
RAIN ExitRAIN ONCOLOGY INC$0-2,034,552
-100.0%
-0.54%
DAWN ExitDAY ONE BIOPHARMACEUTICALS I$0-196,425
-100.0%
-0.74%
ExitPEPGEN INC$0-651,050
-100.0%
-1.01%
EYPT ExitEYEPOINT PHARMACEUTICALS INC$0-432,000
-100.0%
-1.06%
ExitSYROS PHARMACEUTICALS INC$0-881,450
-100.0%
-1.07%
JANX ExitJANUX THERAPEUTICS INC$0-360,414
-100.0%
-1.11%
NKTX ExitNKARTA INC$0-2,868,035
-100.0%
-1.22%
IMCR ExitIMMUNOCORE HLDGS PLCads$0-80,963
-100.0%
-1.29%
ExitPRIME MEDICINE INC$0-470,304
-100.0%
-1.37%
IMTX ExitIMMATICS N.V$0-396,000
-100.0%
-1.40%
ACRS ExitACLARIS THERAPEUTICS INC$0-696,171
-100.0%
-1.46%
GOSS ExitGOSSAMER BIO INC$0-6,130,268
-100.0%
-1.56%
ExitIO BIOTECH INC$0-3,640,015
-100.0%
-1.57%
VRNA ExitVERONA PHARMA PLCsponsored ads$0-347,500
-100.0%
-1.73%
STRO ExitSUTRO BIOPHARMA INC$0-1,675,579
-100.0%
-1.78%
INZY ExitINOZYME PHARMA INC$0-1,562,500
-100.0%
-2.01%
ExitTANGO THERAPEUTICS INC$0-630,000
-100.0%
-2.17%
RYTM ExitRHYTHM PHARMACEUTICALS INC$0-345,293
-100.0%
-2.42%
ExitZYMEWORKS INC$0-1,458,875
-100.0%
-2.83%
AVDL ExitAVADEL PHARMACEUTICALS PLCsponsored adr$0-967,527
-100.0%
-3.05%
ExitHILLEVAX INC$0-799,274
-100.0%
-3.29%
LYRA ExitLYRA THERAPEUTICS INC$0-2,780,261
-100.0%
-3.33%
ICPT ExitINTERCEPT PHARMACEUTICALS IN$0-640,688
-100.0%
-3.64%
GRPH ExitGRAPHITE BIO INC$0-8,459,314
-100.0%
-6.42%
ExitARCELLX INC$0-613,921
-100.0%
-6.74%
ExitACELYRIN INC$0-2,381,579
-100.0%
-7.41%
SRRK ExitSCHOLAR ROCK HLDG CORP$0-4,598,828
-100.0%
-10.00%
ExitRAYZEBIO INC$0-1,845,948
-100.0%
-12.54%
ExitMINERALYS THERAPEUTICS INC$0-4,519,361
-100.0%
-13.16%
Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
Intercept Pharmaceuticals Inc20Q3 202324.0%
ALLAKOS INC20Q3 202323.0%
SUTRO BIOPHARMA INC20Q3 202310.1%
SYROS PHARMACEUTICALS INC16Q3 202211.6%
ATRECA INC16Q1 20237.4%
IVERIC BIO INC15Q2 20235.5%
ACLARIS THERAPEUTICS INC15Q3 20234.8%
RHYTHM PHARMACEUTICALS INC15Q3 20232.4%
ODONATE THERAPEUTICS INC14Q1 202214.9%
SPRINGWORKS THERAPEUTICS INC14Q4 202212.1%

View Samsara BioCapital, LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR/A2023-08-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR/A2023-02-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16

View Samsara BioCapital, LLC's complete filings history.

Compare quarters

Export Samsara BioCapital, LLC's holdings